Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of KI1107 in Patients with Hypertriglyceridemia and Controlled LDL-C
NCT03026933Phase 3Completed
- Sponsor
- Kuhnil Pharmaceutical
- Start
- May 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in hypertriglyceridemia, sponsored by Kuhnil Pharmaceutical. Started May 2014; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT03026933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026933.